Cargando…
Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review
Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of antithrombotic agents and differing guidelines contribute to practice variations and increased risk...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ubiquity Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374022/ https://www.ncbi.nlm.nih.gov/pubmed/36051325 http://dx.doi.org/10.5334/gh.1142 |
_version_ | 1784767707828191232 |
---|---|
author | Cardona, Magnolia Craig, Louise Jones, Mark Byambasuren, Oyungerel Obucina, Mila Hattingh, Laetitia Clark, Justin Glasziou, Paul Hoffmann, Tammy |
author_facet | Cardona, Magnolia Craig, Louise Jones, Mark Byambasuren, Oyungerel Obucina, Mila Hattingh, Laetitia Clark, Justin Glasziou, Paul Hoffmann, Tammy |
author_sort | Cardona, Magnolia |
collection | PubMed |
description | Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of antithrombotic agents and differing guidelines contribute to practice variations and increased risk of complications and deaths. The objective of this review was to investigate the extent of overuse and underuse of antithrombotics for primary or secondary prevention as measured by deviation from prescribing guideline recommendations. We conducted a systematic review of Medline and EMBASE for quantitative articles published between 2000 and 2021 and used a modified version of the Hoy’s risk of bias assessment tool. Here we report evidence from the past decade about wide practice variations in hospitals and primary care, and discuss clinician and patient-driven determinants of non-adherence to guidelines. Finally, we summarise implications for practice, identify enhanced ways of measuring overuse and underuse, and propose potential solutions to the measurement challenges. |
format | Online Article Text |
id | pubmed-9374022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Ubiquity Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-93740222022-08-31 Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review Cardona, Magnolia Craig, Louise Jones, Mark Byambasuren, Oyungerel Obucina, Mila Hattingh, Laetitia Clark, Justin Glasziou, Paul Hoffmann, Tammy Glob Heart Review Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of antithrombotic agents and differing guidelines contribute to practice variations and increased risk of complications and deaths. The objective of this review was to investigate the extent of overuse and underuse of antithrombotics for primary or secondary prevention as measured by deviation from prescribing guideline recommendations. We conducted a systematic review of Medline and EMBASE for quantitative articles published between 2000 and 2021 and used a modified version of the Hoy’s risk of bias assessment tool. Here we report evidence from the past decade about wide practice variations in hospitals and primary care, and discuss clinician and patient-driven determinants of non-adherence to guidelines. Finally, we summarise implications for practice, identify enhanced ways of measuring overuse and underuse, and propose potential solutions to the measurement challenges. Ubiquity Press 2022-08-12 /pmc/articles/PMC9374022/ /pubmed/36051325 http://dx.doi.org/10.5334/gh.1142 Text en Copyright: © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Cardona, Magnolia Craig, Louise Jones, Mark Byambasuren, Oyungerel Obucina, Mila Hattingh, Laetitia Clark, Justin Glasziou, Paul Hoffmann, Tammy Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review |
title | Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review |
title_full | Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review |
title_fullStr | Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review |
title_full_unstemmed | Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review |
title_short | Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review |
title_sort | guideline adherence as an indicator of the extent of antithrombotic overuse and underuse: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374022/ https://www.ncbi.nlm.nih.gov/pubmed/36051325 http://dx.doi.org/10.5334/gh.1142 |
work_keys_str_mv | AT cardonamagnolia guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview AT craiglouise guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview AT jonesmark guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview AT byambasurenoyungerel guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview AT obucinamila guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview AT hattinghlaetitia guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview AT clarkjustin guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview AT glaszioupaul guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview AT hoffmanntammy guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview |